Login / Signup

Characterization of Apparently Paradoxical Thyrotropin Binding Inhibitory Immunoglobulins With Neutral Bioactivity.

Tetsuya TagamiKenji Moriyama
Published in: Journal of the Endocrine Society (2022)
We present here the TBIIs with neutral bioactivities found in the patient with autoimmune thyroid disease, which strongly inhibit TSH binding to the TSH-R but exerts neither TSAb nor TSBAb activity. Differences in the methods of detecting TRAb between TBII in vitro and bioassay may cause the discrepancy. Although serum sample S may be an extreme example, a variety of TRAb that not only stimulates or blocks but also interferes with TSH-R binding for only a short time may exist in the serum samples of GD patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • multiple sclerosis
  • peritoneal dialysis
  • prognostic factors
  • case report
  • binding protein
  • dna binding